A detailed history of Senator Investment Group LP transactions in Legend Biotech Corp stock. As of the latest transaction made, Senator Investment Group LP holds 155,000 shares of LEGN stock, worth $6.23 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
155,000
Previous 165,000 6.06%
Holding current value
$6.23 Million
Previous $9.25 Million 25.83%
% of portfolio
0.34%
Previous 0.43%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 19, 2024

SELL
$39.5 - $57.22 $395,000 - $572,200
-10,000 Reduced 6.06%
155,000 $6.86 Million
Q1 2024

May 14, 2024

BUY
$55.06 - $69.99 $2.75 Million - $3.5 Million
50,000 Added 43.48%
165,000 $9.25 Million
Q4 2023

Feb 14, 2024

BUY
$57.25 - $69.74 $1.43 Million - $1.74 Million
25,000 Added 27.78%
115,000 $6.92 Million
Q2 2023

Aug 11, 2023

BUY
$46.28 - $75.01 $4.17 Million - $6.75 Million
90,000 New
90,000 $6.21 Million

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $6.73B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Senator Investment Group LP Portfolio

Follow Senator Investment Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Senator Investment Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Senator Investment Group LP with notifications on news.